Internal Medicine Alert - April 30, 2013

Target Audience:

This CME activity is intended for the internist/family physician.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/15/13. Term of approval is for one year from this date with the option of yearly renewal.

Faculty Listing:

Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Associate Editors
Rahul Gupta, MD, MPH, FACP
Clinical Assistant Professor
West Virginia University School of Medicine
Charleston, WV

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD

Clinical Assistant Professor
University of Florida
Gainesville

Authors
Betty Tran, MD, MS
Assistant Professor of Medicine
Pulmonary and Critical Care Medicine
Rush University Medical Center
Chicago

Robert L. Coleman, MD
Professor
University of Texas;
M.D. Anderson Cancer Center
Houston

Peer reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Subjects:

  • Does MRI Have Your Patient's Back?
  • Doxycycline May Protect Against Clostridium Difficile Infection
  • "˜Off-target' Effects? The Role of Statins in Cancer Biology
  • Pharmacology Update: Canagliflozin Tablets (Invokana„¢)
  • Omalizumab for Asthma in Real Life
  • Tenofovir: New Hope for Hepatitis B Patients
  • H. pylori: Frequency of Recurrence After Successful Eradication

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease
  • identify cost-effective treatment regimens
  • explain the advantages and disadvantages of new disease screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory board for Lilly, Boehringer Ingelheim, Novo Nordisk, Sunovion, and Teva; he serves on the speakers bureau of Boehringer Ingelheim, Lilly, Kowa, Novo Nordisk, and Teva.

Associate editors Rahul Gupta, MD, MPH, FACP, William T. Elliott, MD, FACP, , and James Chan, PharmD, PhD, Authors Betty Tran, MD, MS, and Robert L. Coleman, MD, Peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Associate editor Louis Kuritzky, MD is an advisor for Endo, Kowa, Pricara, and Takeda.

Copyright 2013 AHC Media. All rights reserved.